PADCEV
Google image searchProduct monograph
Active ingredient
enfortumab vedotin, 30 MG/VIAL
DIN: 02521911
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription / Schedule D
Company: SEAGEN INC.
Date: 10-JAN-2023
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
- L01FX13 — ENFORTUMAB VEDOTIN (ATC/DDD)
